These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1473003)

  • 1. The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids.
    Lambert GA; Lowy AJ; Boers PM; Angus-Leppan H; Zagami AS
    Brain Res; 1992 Dec; 597(2):321-30. PubMed ID: 1473003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study.
    Hoskin KL; Kaube H; Goadsby PJ
    Brain; 1996 Feb; 119 ( Pt 1)():249-56. PubMed ID: 8624686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
    Looper ML; Edrington TS; Moubarak AS; Callaway TR; Rosenkrans CF
    Foodborne Pathog Dis; 2008 Oct; 5(5):599-604. PubMed ID: 18681792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat.
    Lambert GA; Goadsby PJ; Zagami AS; Duckworth JW
    Brain Res; 1988 Jun; 453(1-2):143-9. PubMed ID: 3261196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical spinal cord neurons receiving sensory input from the cranial vasculature.
    Lambert GA; Zagami AS; Bogduk N; Lance JW
    Cephalalgia; 1991 May; 11(2):75-85. PubMed ID: 1677613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
    Roquebert J; Grenié B
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):30-7. PubMed ID: 2881518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergence of occipital nerve and superior sagittal sinus input in the cervical spinal cord of the cat.
    Angus-Leppan H; Lambert GA; Michalicek J
    Cephalalgia; 1997 Oct; 17(6):625-30; discussion 623. PubMed ID: 9350381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence of afferents from superior sagittal sinus and tooth pulp on cells in the upper cervical spinal cord of the cat.
    Angus-Leppan H; Olausson B; Boers P; Lambert GA
    Neurosci Lett; 1994 Dec; 182(2):275-8. PubMed ID: 7715826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ergot alkaloids on sulfonylurea-stimulated insulin secretion in dogs.
    Sirek A; Sirek OV; Policova Z; Kerekes A
    Pharmacology; 1977; 15(3):259-67. PubMed ID: 405680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric secretagogue action of ergot alkaloids in the perfused stomach of anesthetized rats.
    Maeda-Hagiwara M; Watanabe K
    Eur J Pharmacol; 1982 Apr; 79(1-2):105-10. PubMed ID: 7084301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A relay for input from group II muscle afferents in sacral segments of the cat spinal cord.
    Jankowska E; Riddell JS
    J Physiol; 1993 Jun; 465():561-80. PubMed ID: 8229850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.
    Stürmer E
    Cardiology; 1976; 61 suppl 1():290-301. PubMed ID: 975143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergotamine and dihydroergotamine enhance guanylate cyclase activity.
    Vesely DL
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):245-54. PubMed ID: 6136069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cytochrome P450 metabolism by ergonovine and dihydroergotamine.
    Moubarak AS; Rosenkrans CF; Johnson ZB
    Vet Hum Toxicol; 2003 Feb; 45(1):6-9. PubMed ID: 12583687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD
    Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of ergot alkaloids (ergotamine and dihydroergotoxin) on the functional effects of cerebral ischemia in the cat.
    Boismare F; Streichenberger G
    Pharmacology; 1974; 12(3):152-9. PubMed ID: 4216904
    [No Abstract]   [Full Text] [Related]  

  • 17. Craniovascular nociceptive pathways relay in the upper cervical spinal cord in the cat.
    Angus-Leppan H; Lambert GA; Boers P; Zagami AS; Olausson B
    Neurosci Lett; 1992 Mar; 137(2):203-6. PubMed ID: 1584461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
    Storer RJ; Goadsby PJ
    Brain; 1997 Dec; 120 ( Pt 12)():2171-7. PubMed ID: 9448572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ergotamine and dihydroergotamine on cerebral blood flow in man.
    Andersen AR; Tfelt-Hansen P; Lassen NA
    Stroke; 1987; 18(1):120-3. PubMed ID: 3810743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.
    Glusa E; Roos A
    Br J Pharmacol; 1996 Sep; 119(2):330-4. PubMed ID: 8886417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.